Michelle Lugo
Nurse Practitioner · Denver, CONPI 1477126209
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,083 of the $2,683 with a category attached, or 77.6%. 27 manufacturers reported payments, led by AbbVie at 43.4% of the total. Reporting peaked in 2021 at $880 and has fallen 79.7% since, to $179 in 2025. Among nurse practitioner clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $30.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Amgen$265
- Alkermes, Inc.$221
- AstraZeneca$157
- Hologic Sales And Service, LLC$140
- Lilly USA, LLC$52
- plus $683 from 21 others
What the payments were for
- Consulting fees$60022%
- Food & beverage$2,08378%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $1,165 |
| Amgen | 11 | $265 |
| Alkermes, Inc. | 6 | $221 |
| AstraZeneca | 4 | $157 |
| Hologic Sales And Service, LLC | 6 | $140 |
| Lilly USA, LLC | 4 | $52 |
| GSK | 3 | $52 |
| Johnson & Johnson(2 entities) | 2 | $48 |
| Edwards Lifesciences | 2 | $46 |
| Astellas Pharma US Inc | 2 | $46 |
| Avanir Pharmaceuticals, Inc. | 2 | $44 |
| Merck | 3 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Sunovion Pharmaceuticals Inc. | 2 | $38 |
| Novo Nordisk | 2 | $38 |
| Inogen, Inc. | 2 | $37 |
| Pfizer | 2 | $35 |
| Sanofi Pasteur Inc. | 1 | $29 |
| Bayer | 1 | $27 |
| Telix Pharmaceuticals | 1 | $24 |
| Recordati_rare_diseases_inc. | 1 | $22 |
| Boston Scientific | 1 | $22 |
| Novartis | 1 | $20 |
| Morphosys, US Inc. | 1 | $19 |
| Indivior Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,683 in reported general payments places this provider in the 90th percentile of 1,384 nurse practitioner providers in Colorado.
Other nurse practitioner in Denver
- Christina ProulxDenver$28K
- Jose Diaz LeoDenver$24K
- Lolanda McBrideDenver$20K
- Cori FratelliDenver$15K
- Leslie HindsDenver$9K
- Rebecca AndrieDenver$8K
- Nahid Kuseh Kalani YazdDenver$8K
- Amber Whitton-SmithDenver$7K
- Jacqueline CarboneDenver$7K
- Stephanie WyttenbachDenver$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.